These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells. Furuyama K; Chera S; van Gurp L; Oropeza D; Ghila L; Damond N; Vethe H; Paulo JA; Joosten AM; Berney T; Bosco D; Dorrell C; Grompe M; Ræder H; Roep BO; Thorel F; Herrera PL Nature; 2019 Mar; 567(7746):43-48. PubMed ID: 30760930 [TBL] [Abstract][Full Text] [Related]
12. In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors. Yang XF; Ren LW; Yang L; Deng CY; Li FR Endocr J; 2017 Mar; 64(3):291-302. PubMed ID: 28100871 [TBL] [Abstract][Full Text] [Related]
13. Establishing a Large-Animal Model for In Vivo Reprogramming of Bile Duct Cells into Insulin-Secreting Cells to Treat Diabetes. Hill CM; Banga A; Abrahante JE; Yuan C; Mutch LA; Janecek J; O'Brien T; Graham ML; Dutton JR Hum Gene Ther Clin Dev; 2017 Jun; 28(2):87-95. PubMed ID: 28363269 [TBL] [Abstract][Full Text] [Related]
14. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells. Sharma A; Rani R Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182 [TBL] [Abstract][Full Text] [Related]
15. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming. Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262 [TBL] [Abstract][Full Text] [Related]